4//SEC Filing
BIENAIME JEAN JACQUES 4
Accession 0001415889-25-015971
CIK 0001664710other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:15 PM ET
Size
7.3 KB
Accession
0001415889-25-015971
Insider Transaction Report
Form 4
BIENAIME JEAN JACQUES
Director
Transactions
- Award
Common Stock
2025-06-04+5,250→ 5,450 total - Award
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 totalExercise: $14.82Exp: 2035-06-03→ Common Stock (10,500 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs fully vest on the earlier of (A) June 4, 2026 and (B) the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001221590
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:15 PM ET
- Size
- 7.3 KB